YOLFTbeta
Adagio Medical Holdings, Inc Common Stock

Adagio Medical Holdings, Inc Common Stock

ADGM · NASDAQ · Healthcare / Medical Devices

1.93USD+0.11 (+6.04%)

Price History

Full chart

Market Stats

Previous Close1.82
Open1.82
Day Range1.82 – 1.96
52-Week Range0.1755 – 2.58
Volume36.05K
Market Cap4.66M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.26
Dividend Yield0.00%
Beta-0.09
50-Day Avg0.5454
200-Day Avg0.8635

About

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Todd Usen
  • Employees41
  • Headquarters26051 Merit Circle, Laguna Hills, CA, United States, 92653, USA
  • Websitehttps://adagiomedical.com

Leadership

  • Mr. Todd UsenCEO & Director · b. 1967
  • Ms. Deborah KasterCFO & Chief Business Officer · b. 1971
  • Mr. Antwan Gipson M.B.A.Senior Vice President of Manufacturing & Operations
  • Dr. Alex Babkin Ph.D.Chief Technical Officer
  • Mr. Nabil JubranChief Compliance Officer
  • Mr. Ilya GrigorovVice President of Global Marketing & Product Management
  • Ms. Marie-Claude JacquesSenior Vice President of Global Sales · b. 1985
  • Ms. Maryline CullenVP & Corporate Controller

Financials

Income Statement

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-270.00K189.00K300.00K269.00K0
Growth (%)---30.00%+58.73%-10.33%-100.00%
Cost of Revenue-1.16M875.00K1.31M1.94M684.00K
Gross Profit--888.00K-686.00K-1.01M-1.67M-684.00K
Gross Margin--328.89%-362.96%-335.33%-620.07%-
Operating Expense-19.76M23.23M26.94M60.81M21.21M
Operating Income-13.54K-20.64M-23.91M-27.94M-62.48M-21.89M
Operating Margin--7646.30%-12652.38%-9314.00%-23226.77%-
EBITDA-13.54K-19.60M-23.04M-35.95M-53.48M-21.21M
EBITDA Margin--7260.00%-12191.01%-11985.00%-19881.78%-
Net Income-13.54K-19.94M-23.67M-38.15M-53.76M-25.08M
Net Income Margin--7384.44%-12525.40%-12715.33%-19986.25%-
R&D-15.36M17.86M15.40M4.63M10.64M
R&D as % of Total Revenue-5687.04%9447.09%5133.00%1722.68%-
Interest Expense-0137.00K1.66M1.10M2.91M
Interest Expense % of Total Revenue-0.00%72.49%553.00%409.67%-

Balance Sheet

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets42.45K21.44M8.70M6.83M48.45M43.25M
Total Liabilities55.99K94.06M104.57M138.85M28.54M30.85M
Total Equity-13.54K-72.62M-95.88M-132.02M19.91M12.40M
Cash-18.85M5.55M1.38M20.59M17.11M
Total Debt11.22K-9.80M38.40M16.27M21.76M
Net Debt11.22K-18.85M4.25M37.02M-4.32M4.65M

Cash Flow

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-19.31M-22.41M-725.86K-29.46M-19.01M
Investing Cash Flow-1.27M-500.00K113.67M-1.65M-374.00K
Financing Cash Flow130.00K9.53M-113.02M15.63M16.13M
Capital Expenditure1.27M492.00K21.65M374.00K
Free Cash Flow-20.58M-22.90M-725.86K-31.11M-19.39M
FCF to OCF106.59%102.20%100.00%105.59%101.97%

Earnings

Report DateMay 13, 2021Aug 12, 2021Nov 12, 2021Mar 31, 2022May 13, 2022Aug 8, 2022Nov 7, 2022Dec 31, 2022Apr 6, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Mar 27, 2025May 15, 2025Aug 14, 2025Nov 12, 2025Mar 27, 2026May 12, 2026Aug 11, 2026Nov 11, 2026
EPS Estimate------------------0.00-0.31-0.29-0.38-0.30
EPS Actual-0.01-0.01-0.27-0.06-0.01-0.010.17-0.090.050.05-0.06-0.28-0.03-6.44-0.32-3.75-0.51-0.35-0.66-0.16-0.31-0.30-
Surprise-------------------48.39%-6.90%21.05%-
Timing-------------------Pre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap4.66M
Enterprise Value23.32M
Trailing P/E0.00
Forward P/E0.00
Price / Sales205.85
Price / Book2.89
EPS-1.26
Book Value-0.019
Revenue (TTM)137.00K
Gross Profit (TTM)-89.00K
EBITDA-18.98M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-657.76%
Return on Assets-35.52%
Shares Outstanding22.21M
Shares Float8.41M
Beta-0.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
67.86%
Insiders
1.17%
Retail / Other
30.97%

Top Institutional Holders

  • Perceptive Advisors LLC
    9.88M44.47%
  • Adage Capital Partners Gp LLC
    1.26M5.67%
  • ADAR1 Capital Management LLC
    1.21M5.43%
  • Alyeska Investment Group, L.P.
    1.16M5.22%
  • Sio Capital Management, LLC
    698.99K3.15%
  • SILVERARC CAPITAL MANAGEMENT, LLC
    251.97K1.13%
  • Shaolin Capital Management LLC
    171.17K0.77%
  • Geode Capital Management, LLC
    125.24K0.56%
  • Affinity Asset Advisors, LLC
    80.00K0.36%
  • Vanguard Fiduciary Trust Co
    53.78K0.24%
  • Vanguard Capital Management, LLC
    39.61K0.18%
  • The Toronto-Dominion Bank
    25.00K0.11%
  • XTX Topco Ltd
    23.35K0.11%
  • Northern Trust Corp
    21.60K0.10%
  • Opaleye Management Inc
    18.44K0.08%
  • Renaissance Technologies Corp
    16.56K0.07%
  • Citadel Advisors Llc
    16.16K0.07%
  • Bank of America Corp
    12.86K0.06%

Top Fund Holders

  • Fidelity Extended Market Index
    50.76K0.23%
  • Vanguard MStar Total Stk Mkt Idx Invest
    17.44K0.08%

Stock Splits

  • Nov 9, 20261:30